Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
Results 81 - 100
of 233
Sort by Relevance
|
Sort by Date
11 Nov 2013, 5:48 am
Sharon Hausdorff (Deputy General Patent Counsel, Teva Pharmaceutical Industries Ltd) then addressed "Due diligence". [read post]
10 Nov 2013, 6:37 am
"From IP to NP (Net Profit)" continued after a tasty and ample lunch break with a further parallel session, with the first pair of topics offered a choice between enforcing rights and getting them in the first place: 1 (for IP Professionals) Enforcement of IP Rights in US, Europe, Asia and Israel 2 (for entrepreneurs and IP managers) Seminar on IP Rights Registration in a Constantly Changing World, Part A: Claim Construction & Implications Again, this… [read post]
30 Jul 2013, 2:53 pm
One such case is Generics [UK] Ltd (t/a Mylan) v Yeda Research And Development Co Ltd and Teva Pharmaceutical Industries Ltd [2013] EWCA Civ 925, decided yesterday by a three-man Court of Appeal for England and Wales which consisted of two specialist IP judges -- Lords Justices Kitchin and Floyd -- together with Lord Justice Moses. [read post]
3 Apr 2013, 4:45 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
30 Nov 2012, 6:00 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
30 Nov 2012, 6:00 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
13 Nov 2012, 5:43 pm
The European Commission (EC) announced on November 12 that it has cleared Procter & Gamble Company's proposed acquisition of the over-the-counter (OTC) business of the generic pharmaceutical company Teva Pharmaceutical Industries, Ltd. of Israel. [read post]
11 Sep 2012, 5:30 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
27 Aug 2012, 9:31 am
Hoffmann-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
27 Aug 2012, 9:31 am
Hoffmann-La Roche Ltd., 580 F.3d 1340 (Fed. [read post]
3 Aug 2012, 1:56 pm
The Securities and Exchange Commission is investigating Teva Pharmaceutical Industries Ltd, the world’s largest manufacturer of generic drugs, for possible violations of a U.S. anti-bribery law. [read post]
21 Jun 2012, 11:46 am
Teva Pharmaceuticals USA, Inc. [read post]
1 Jun 2012, 1:58 pm
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®ShareTweetTeva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
5 Apr 2012, 11:54 am
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
24 Mar 2012, 1:20 pm
CAFC Rules “Secret Prior Art” Requires Only Appreciation that Invention Made in Teva Pharmaceutical*The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
11 Mar 2012, 8:16 pm
Bloomberg: Teva Pharmaceutical Seeks to Intervene in Plan B Lawsuit, by Thom Weidlich: Teva Pharmaceutical Industries Ltd. [read post]
29 Jan 2012, 2:08 pm
Teva Pharmaceutical Industries Ltd. and its U.S. subsidiary Cephalon has recalled a lot of its Treanda leukemia drug, because glass fragments were found in one of the vials. [read post]
7 Dec 2011, 9:59 pm
Ltd. v. [read post]
CAFC Rules “Secret Prior Art” Requires Only Appreciation that Invention Made in Teva Pharmaceutical*
4 Dec 2011, 8:46 am
The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
